Carolyn Szwed

Dr. Carolyn Szwed

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
CSCarolyn Szwed
Carolyn Szwed
LBLeszek Blicharz
Leszek Blicharz
MKMagdalena Knetki-Wróblewska
Magdalena Knetki-Wróblewska
LRLidia Rudnicka
Lidia Rudnicka
JCJoanna Czuwara
Joanna Czuwara
Amivantamab plus lazertinib (amivantamab+lazertinib) is a novel combination therapy used to treat epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). Although this regimen has demonstrated clinical efficacy in locally advanced or metastatic NSCLC, it is associated with a range of dermatologic adverse events that may develop rapidly and require prompt intervention. Early management of these side effects is critical for maintaining oncologic treatment, optimizing clinical outcomes, and improving patients’ quality of life. Cases: We present four patients with EGFR-mutated NSCLC who experienced dermatologic adverse events during amivantamab+lazertinib therapy. Two developed severe facial papulopustular eruptions, and two presented with necrotic folliculitis with sanguineous scalp erosions. Additional dermatologic manifestations included paronychia, pruritus, xerosis, mucositis, and trichomegaly. Notably, one patient experienced milder dermatologic side effects due to early initiation of a dermatologic prophylactic regimen. Conclusions: Dermatologic adverse events during amivantamab+lazertinib therapy are frequent and may be more severe than those typically observed with EGFR inhibitors. Early prophylactic measures and timely intervention are essential for managing these adverse events, supporting treatment adherence, and maximizing the therapeutic efficacy of this combined oncologic regimen.

9 January 2026 in Skin Research and Technology
Verified
Journal Article
Open access
UFUrszula Fałkowska
Urszula Fałkowska
ADAneta Durmaj
Aneta Durmaj
CSCarolyn Szwed
Carolyn Szwed
MKMarta Kurzeja
Marta Kurzeja
JCJoanna Czuwara
Joanna Czuwara
MOMalgorzata Olszewska
Malgorzata Olszewska
Background: Desquamative gingivitis is a clinical condition characterized by erythema, blisters, and erosions within the gingiva. It may be a manifestation of oral lichen planus or autoimmune bullous diseases, such as pemphigus vulgaris and mucous membrane pemphigoid. The identification of the cause of desquamative gingivitis typically involves the analysis of clinical manifestations, histopathology, and immunopathology evaluation. This article reviews available data on the application of noninvasive imaging techniques (reflectance confocal microscopy, optical coherence tomography, and line‐field confocal optical coherence tomography) in identifying the cause of desquamative gingivitis. Materials and Methods: The review of the literature for desquamative gingivitis was performed by searching the PubMed, Scopus, and Wiley databases up to January 2025. Results: This study aimed to evaluate the applicability of noninvasive imaging techniques, including RCM, OCT, and LC‐OCT, in the differential diagnosis of desquamative gingivitis. Findings suggest these modalities offer characteristic diagnostic patterns across underlying diseases. In oral lichen planus, RCM typically shows disrupted connective tissue papillae, obscured basement membranes, and inflammatory cell infiltrates. In pemphigus vulgaris, the key findings are acantholytic keratinocytes and intraepithelial clefts, while mucous membrane pemphigoid displays subepithelial clefts and signs of hemorrhage. OCT findings in desquamative gingivitis associated with oral lichen planus include maintained epithelial thickness in the erosive forms and multilocular blisters in the bullous variants of the disease. In pemphigus vulgaris, OCT reveals intraepithelial clefts and thinning of the epithelium, while mucous membrane pemphigoid is marked by subepithelial blister formation and fluid accumulation. Conclusion: New noninvasive imaging techniques, such as reflectance confocal microscopy and optical coherence tomography, may support clinical decision‐making, improve biopsy targeting, and enhance long‐term monitoring of desquamative gingivitis.

27 December 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
CSCarolyn Szwed
Carolyn Szwed
Olivia GudziewskiOlivia Gudziewski
Olivia Gudziewski
MSMarta Sar-Pomian
Marta Sar-Pomian
MOMalgorzata Olszewska
Malgorzata Olszewska
LRLidia Rudnicka
Lidia Rudnicka
JCJoanna Czuwara
Joanna Czuwara
Background: Lichen planus (LP) is a chronic inflammatory disease that can present with significant morbidity, particularly in children. Erosive lichen planus (ELP), its rare destructive subtype, can be particularly difficult to diagnose and manage. We present a rare pediatric case of ELP with multisite involvement and discuss the differential diagnosis. Case Presentation: A 12-year-old boy presented with painful erosions and ulcers on the lateral tongue and dystrophic nails. His six-year history of tongue and nail lesions prompted several comprehensive examinations. Laboratory tests did not reveal any abnormalities. Histopathological examination of the tongue lesions was representative of ELP. Line-field confocal optical coherence tomography (LC-OCT) examination of the tongue lesions showed features that strongly correlated with histopathology. The patient was later hospitalized due to dysphagia and esophageal food impaction, during which esophageal ELP was confirmed. The patient was initially managed with topical corticosteroids. He was later started on systemic therapy in the form of methotrexate and low-dose naltrexone to address his symptoms and disease presentation. Conclusions: This case highlights the complexities of diagnosis and management of ELP in pediatric patients. A multidisciplinary approach and regular follow-up are necessary to manage symptoms, prevent complications, and improve quality of life.

9 December 2024 in Polish Journal of Pathology
Verified
Journal Article
Closed access
CSCarolyn Szwed
Carolyn Szwed
MMMalgorzata Maj
Malgorzata Maj
LRLidia Rudnicka
Lidia Rudnicka
JCJoanna Czuwara
Joanna Czuwara
Multinucleate cell angiohistiocytoma (MCAH) is a rare benign cutaneous entity. It classically presents as slowly progressive erythematous to violaceous papules on the distal extremities of middle-aged or elderly women. The entity may clinically resemble granuloma annulare, lichen planus, and several cutaneous vascular proliferations. Histologically, MCAH is characterized by vascular proliferation within the upper and mid-dermis, a mild perivascular inflammatory infiltrate, and charac­teristic bizarre-shaped multinucleate cells. To date, less than 200 cases have been reported in the literature. We present five of the best examples diagnosed in our department to further elucidate this peculiar entity for pathological recognition.

10 November 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
CSCarolyn Szwed
Carolyn Szwed
FUFalkowska Urszula
Falkowska Urszula
MKMarta Kurzeja
Marta Kurzeja
MOMalgorzata Olszewska
Malgorzata Olszewska
LRLidia Rudnicka
Lidia Rudnicka
JCJoanna Czuwara
Joanna Czuwara
Oral lichen planus (OLP) and oral lichenoid lesions (OLLs) are common oral mucosal diseases that may be difficult to differentiate due to their clinical and histological similarities. Despite overlapping features, they require appropriate diagnosis given different etiologies, management strategies, and prognoses. OLP is a chronic, immune-mediated disease of unknown etiology, typically presenting as bilateral, symmetrical reticular lesions, erosions, or plaques on the buccal mucosa, gingiva, and tongue. In contrast, OLLs classically manifest as unilateral, asymmetrical lesions often associated with identifiable causes such as contact allergens, medications, or systemic diseases. Histologically, both OLP and OLLs may exhibit basal cell degeneration and a subepithelial lymphocytic infiltrate; however, OLLs often display deeper, mixed-cell, and perivascular inflammation. Clinically, OLP usually follows a chronic course, poses therapeutic challenges, and requires long-term surveillance due to its malignant transformation potential. OLLs may resolve following identification and elimination of the inciting factor; however, persistent OLLs may also carry a risk of malignant transformation and therefore warrant regular follow-up. Accurate diagnosis of OLP and OLLs requires a comprehensive approach that includes thorough medical history, clinical, histological, and immunological examinations, with novel non-invasive imaging techniques potentially offering adjunctive diagnostic support. This narrative review aims to synthesize current knowledge on OLP and OLLs, with particular emphasis on their key diagnostic features.